News
OncClub
All Oncology News
Pipeline Report
Media
Insights
Medical World News
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conferences
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
OncologyLive
Oncology Fellows
Supplements And Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Presentations
Sponsored
Subscribe
Print Subscription
eNewsletter

logo
Spotlight
OncClub: Join the Chat on Trending Trials in Cancer
In-person and virtual events just for HCPs
Specialty
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
OncClub
All Oncology News
Pipeline Report
Insights
Medical World News
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conference Coverage
Conference Listing
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
OncologyLive
Oncology Fellows
Supplements And Featured Publications
All Publications
CME/CE
Interactive Tools
Learning Modules
Presentations
Sponsored
Print Subscription
eNewsletter
Advertisement
Urothelial Cancer
| Breast Cancer
| Lung Cancer
| Gastrointestinal Cancer
| Genitourinary Cancers
| Ovarian Cancer
| Prostate Cancer
| Melanoma & Skin Cancer
| Mantle Cell Lymphoma
| Myeloproliferative Neoplasms
| Biosimilars
| Brain Cancer
| Business Management
| CAR T-cell Therapy
| COVID-19
| Chronic Lymphocytic Leukemia
| Colorectal Cancer
| Disparities in Cancer Care
| Global Oncology
| Gynecologic Oncology
| Head & Neck Cancers
| Hematologic Oncology
| Immuno-Oncology
| Multiple Myeloma
| Neoadjuvant HER2+
| Non-Hodgkin Lymphoma
| Oncology Nursing News
| Pediatric Oncology
| Precision Medicine in Oncology®
| Sarcomas/TGCT
| Supportive Care
View All >>
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
  • Business Management
  • CAR T-cell Therapy
  • COVID-19
  • Chronic Lymphocytic Leukemia
  • Colorectal Cancer
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
  • Genitourinary Cancers
  • Global Oncology
  • Gynecologic Oncology
  • Head & Neck Cancers
  • Hematologic Oncology
  • Immuno-Oncology
  • Lung Cancer
  • Mantle Cell Lymphoma
  • Melanoma & Skin Cancer
  • Multiple Myeloma
  • Myeloproliferative Neoplasms
  • Neoadjuvant HER2+
  • Non-Hodgkin Lymphoma
  • Oncology Nursing News
  • Ovarian Cancer
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Prostate Cancer
  • Sarcomas/TGCT
  • Supportive Care
  • Urothelial Cancer

SPOTLIGHT -

OncClub: Join the Chat on Trending Trials in Cancer
| In-person and virtual events just for HCPs

Precision Medicine in Acute Myeloid Leukemia Treatment

home / peer-exchange / precision-medicine-aml-treatment
Genetic Alterations in Acute Myeloid Leukemia

EP. 1: Genetic Alterations in Acute Myeloid Leukemia

July 22nd 2019
Best Practices for NGS Testing in AML

EP. 2: Best Practices for NGS Testing in AML

July 22nd 2019
Therapeutic Approaches Based on Mutations in AML

EP. 3: Therapeutic Approaches Based on Mutations in AML

July 22nd 2019
Prognostic Significance of MRD in AML

EP. 4: Prognostic Significance of MRD in AML

July 22nd 2019
MRD Assessment and its Clinical Implications in AML

EP. 5: MRD Assessment and its Clinical Implications in AML

July 22nd 2019
Treatment Strategies and Patient Specific Factors in AML

EP. 6: Treatment Strategies and Patient Specific Factors in AML

July 22nd 2019
Consolidation Strategies in AML

EP. 7: Consolidation Strategies in AML

July 22nd 2019
Role of Maintenance Therapy in AML

EP. 8: Role of Maintenance Therapy in AML

July 22nd 2019
Treatment of AML With Myelodysplasia-Related Changes

EP. 9: Treatment of AML With Myelodysplasia-Related Changes

July 22nd 2019
Role of Hypomethylating Agents in AML

EP. 10: Role of Hypomethylating Agents in AML

July 22nd 2019
Management of Adverse Events in Older Patients With AML

EP. 11: Management of Adverse Events in Older Patients With AML

July 22nd 2019
Recent Data on the Treatment of Older Patients With AML

EP. 12: Recent Data on the Treatment of Older Patients With AML

July 22nd 2019
Targeting FLT3 in Patients with Relapsed/Refractory AML

EP. 13: Targeting FLT3 in Patients with Relapsed/Refractory AML

July 22nd 2019
Data Supporting Quizartinib in FLT3+ R/R AML

EP. 14: Data Supporting Quizartinib in FLT3+ R/R AML

July 22nd 2019
Relapsed vs. Refractory Data for FLT3 Inhibitors in AML

EP. 15: Relapsed vs. Refractory Data for FLT3 Inhibitors in AML

July 22nd 2019
Targeting IDH1/2 in AML

EP. 16: Targeting IDH1/2 in AML

July 22nd 2019
The Future Treatment Landscape of AML

EP. 17: The Future Treatment Landscape of AML

July 22nd 2019

Latest Conference Coverage

Dr Berkenstock on ADC-Related Ocular Toxicities in Cervical and Ovarian Cancers

Dr Matalonis on the Management of Mirvetuximab Soravtansine-Related Toxicities in FRα+ Ovarian Cancer

Updated EMPOWER-Lung 3 Data Support Frontline Cemiplimab Plus Chemo in Advanced NSCLC

Neoadjuvant Nivolumab Plus Chemotherapy Retains EFS Advantage in Resectable NSCLC

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
CancerNetwork.com
CGTlive.com
CureToday.com
OncNursingNews.com
TargetedOnc.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact